EUVIMEDEUVIMED entdecken
Crossref

L26/O-041 Decoding the zona pellucida: unimagined features revealed by protein-targeting reverse genetics

M. Boiani, G. Fuellen, H.C.A. Drexler, S. Israel, T. Nolte

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Boiani und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Karl Ernst von Baer was the first to describe the zona pellucida surrounding human oocytes in 1827. Ever since has the zona been known as quintessential extracellular structure of mammalian oocytes. It is composed of glycoproteins (ZP1, ZP2, ZP3, ZP4 in humans; ZP1, ZP2, ZP3 in mice) that are synthesized only during oogenesis and compartmentalized into the secretory pathway. Once secreted and assembled around the oocyte, ZP proteins are tasked with encasing the oocyte in the ovarian follicle, mediating sperm-oocyte interaction while avoiding polyspermy, and preventing premature contact between the embryo and the oviductal epithelium after fertilization. However, sometimes it takes a second look and with different techniques to realize that not all was as it first seemed. It all began when we detected ZP2 and ZP3 proteins in blastocyst-stage mouse embryos, by mass spectrometry, even though we had previously removed the zona with acidic Tyrode’s solution (PMID 31527703). We confirmed the observation with the orthogonal method of immunofluorescence, using monoclonal antibodies that have been proven to be absolutely specific for ZP proteins for the past 40 years. Moreover, the intra-embryonic ZP2 and ZP3 proteins were detected not only in the secretory pathway, but also in the cytosol, based on non-colocalization with markers of the endoplasmic reticulum and Golgi apparatus (PMID 37930049). This cytosolic location is consistent with that of a ZP3 variant described in human ovarian tumors, unable to be secreted as it lacks the signal peptide (‘ZP3 cancer’; PMID 38125942). To shed light on the functional significance of intra-embryonic ZP2 and ZP3 we performed protein knockdown using the method of ‘Trim-Away’ (PMID 29153837) either on its own or in combination with morpholino (PMID 14654215). The former degrades the protein of interest via the proteasome pathway, while the latter prevents mRNA translation and thereby addresses a possible concern of protein replenishment. Off-target effects were discounted by confirming that the monoclonal antibodies produced a single band in immunoblotting of oocyte lysates, and that the morpholinos did not bind anything but Zp mRNA, according to BLAST search. The knockdowns were partial, probably because of the considerable amount of substrate, and because only a fraction of the total is cytosolic and thereby accessible for ‘Trim-Away’. Knockdown of ZP3 resulted in zygotic arrest (PMID 37930049). Knockdown of ZP2 resulted in mouse embryo retardation at the morula stage; and resultant blastocysts presented a reduction in the size of the extra-embryonic compartments (trophectoderm, primitive endoderm) as well as reduction in the rates of post-implantation development (https://www.biorxiv.org/content/10.64898/2025.12.12.692802v1). These phenotypes were not observed upon targeting of an irrelevant protein or mRNA sequence (GFP mock control). Transcriptome (RNA-seq) and proteome (mass spec) analysis of the ZP2 and ZP3 knockdown embryos compared to mock controls hinted at the possible underlying mechanisms: failure of zygotes to regulate genes involved in embryonic genome activation, in the case of ZP3, and failure to regulate genes involved in morula-to-blastocyst transition, in the case of ZP2. Taken together, these findings call into question the traditional model that ZP proteins function solely in the extracellular space and accompany embryogenesis as passive bystanders: on the contrary, ZP proteins seem to participate actively in the intracellular processes of early embryogenesis. Future research will need to clarify how ZP protein can possibly fold outside the secretory compartment, and whether our observations in mice hold true also in humans.

Zitieren

APA

Boiani, M., Fuellen, G., Drexler, H., Israel, S., & Nolte, T. (2026). L26/O-041 Decoding the zona pellucida: unimagined features revealed by protein-targeting reverse genetics. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.041

Vancouver

Boiani M, Fuellen G, Drexler H, Israel S, Nolte T. L26/O-041 Decoding the zona pellucida: unimagined features revealed by protein-targeting reverse genetics. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.041

BibTeX
@article{Boiani2026,
  author = {Boiani, M. and Fuellen, G. and Drexler, H.C.A. and Israel, S. and Nolte, T.},
  title = {L26/O-041 Decoding the zona pellucida: unimagined features revealed by protein-targeting reverse genetics},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.041}
}
Kostenlos starten →